129 related articles for article (PubMed ID: 36124708)
1. Feasibility of olfactomedin 4 as a molecular biomarker for early diagnosis of gastric neoplasia after intestinal metaplasia.
Pang L; Yan X; Su D; Wu X; Jiang H
Scand J Gastroenterol; 2023 Feb; 58(2):133-141. PubMed ID: 36124708
[TBL] [Abstract][Full Text] [Related]
2. Screening key genes and biomarkers in gastrointestinal metaplasia that progress to gastric cancer by integrated bioinformatics analysis.
Pang L; Yan X; Su D
J Physiol Pharmacol; 2021 Dec; 72(6):. PubMed ID: 35485356
[TBL] [Abstract][Full Text] [Related]
3. Potential role of aquaporin 3 in gastric intestinal metaplasia.
Zhao H; Yang X; Zhou Y; Zhang W; Wang Y; Wen J; Zhang Z; Shen L
Oncotarget; 2015 Nov; 6(36):38926-33. PubMed ID: 26506416
[TBL] [Abstract][Full Text] [Related]
4. Gastric intestinal metaplasia - age, ethnicity and surveillance for gastric cancer.
Simko V; Anand N; Ginter E
Bratisl Lek Listy; 2015; 116(1):3-8. PubMed ID: 25666954
[TBL] [Abstract][Full Text] [Related]
5. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
Jang BG; Lee BL; Kim WH
Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
[TBL] [Abstract][Full Text] [Related]
6. Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis?
Kutluana U; Kilciler AG; Mizrak S; Dilli U
Gastroenterol Hepatol; 2019 May; 42(5):289-295. PubMed ID: 30795853
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of confocal laser endomicroscopy for atrophy and gastric intestinal metaplasia: A meta-analysis.
Bai T; Zhang L; Sharma S; Jiang YD; Xia J; Wang H; Qian W; Song J; Hou XH
J Dig Dis; 2017 May; 18(5):273-282. PubMed ID: 28342261
[TBL] [Abstract][Full Text] [Related]
8. DKK1 is epigenetically downregulated by promoter methylation and inhibits bile acid-induced gastric intestinal metaplasia.
Lu W; Ni Z; Tong M; Jiang S; Zhang J; Feng C; Han C; Yuan T; Wang N; Zhao J; Sun N; Liu C; Jia Q; Wu Q; Ning H; Shi Y
Biochem Biophys Res Commun; 2020 Mar; 523(3):780-786. PubMed ID: 31952791
[TBL] [Abstract][Full Text] [Related]
9. Modified Chaishao Liujunzi Decoction inhibits bile acid-induced gastric intestinal metaplasia: from network prediction to experimental verification.
Sun Z; Liu Y; Deng H; Wang S; Zhang J; Xing C; Xu C
Aging (Albany NY); 2023 Dec; 15(23):13998-14018. PubMed ID: 38096029
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic validity and learning curve of non-NBI expert endoscopists in gastric intestinal metaplasia diagnosis.
Tiankanon K; Pittayanon R; Faknak N; Sirimongkolkasem J; Rattanachaisit P; Lerttanatum N; Sanpavat A; Klaikaew N; Rerknimitr R
Surg Endosc; 2023 Sep; 37(9):6771-6778. PubMed ID: 37226035
[TBL] [Abstract][Full Text] [Related]
11. Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric Cancer.
Zhou J; Fan X; Chen N; Zhou F; Dong J; Nie Y; Fan D
J Histochem Cytochem; 2015 Dec; 63(12):922-30. PubMed ID: 26374829
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions.
Huang RJ; Choi AY; Truong CD; Yeh MM; Hwang JH
Gut Liver; 2019 Nov; 13(6):596-603. PubMed ID: 31394893
[TBL] [Abstract][Full Text] [Related]
13. A spatially mapped gene expression signature for intestinal stem-like cells identifies high-risk precursors of gastric cancer.
Huang RJ; Wichmann IA; Su A; Sathe A; Shum MV; Grimes SM; Meka R; Almeda A; Bai X; Shen J; Nguyen Q; Amieva MR; Hwang JH; Ji HP
bioRxiv; 2023 Sep; ():. PubMed ID: 37786704
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Extensive and Limited Gastric Intestinal Metaplasia and Progression to Dysplasia and Gastric Cancer.
Laszkowska M; Truong H; Faye AS; Kim J; Tan SX; Lim F; Abrams JA; Hur C
Dig Dis Sci; 2022 Aug; 67(8):3693-3701. PubMed ID: 34657192
[TBL] [Abstract][Full Text] [Related]
15. Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body.
O'Connor A; Bowden A; Farrell E; Weininger J; Crowther S; McNamara D; Ridgway P; O'Morain C
Dig Dis Sci; 2021 Oct; 66(10):3470-3475. PubMed ID: 33094451
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy.
Huang RJ; Ende AR; Singla A; Higa JT; Choi AY; Lee AB; Whang SG; Gravelle K; D'Andrea S; Bang SJ; Schmidt RA; Yeh MM; Hwang JH
Gastrointest Endosc; 2020 Jan; 91(1):70-77.e1. PubMed ID: 31425693
[TBL] [Abstract][Full Text] [Related]
17. Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma.
Mirza ZK; Das KK; Slate J; Mapitigama RN; Amenta PS; Griffel LH; Ramsundar L; Watari J; Yokota K; Tanabe H; Sato T; Kohgo Y; Das KM
Gut; 2003 Jun; 52(6):807-12. PubMed ID: 12740335
[TBL] [Abstract][Full Text] [Related]
18. Gastric intestinal metaplasia: progress and remaining challenges.
Tong QY; Pang MJ; Hu XH; Huang XZ; Sun JX; Wang XY; Burclaff J; Mills JC; Wang ZN; Miao ZF
J Gastroenterol; 2024 Apr; 59(4):285-301. PubMed ID: 38242996
[TBL] [Abstract][Full Text] [Related]
19. Gastric Intestinal Metaplasia in Mucosa Adjacent to Gastric Cancers Is Rarely Associated With the Aneuploidy That Is Characteristic of Gastric Dysplasia or Cancer.
Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
Am J Surg Pathol; 2021 Oct; 45(10):1374-1381. PubMed ID: 34091484
[TBL] [Abstract][Full Text] [Related]
20. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
